Citations (95)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Susbin Raj Wagle, Bozica Kovacevic, Daniel Walker, Corina Mihaela Ionescu, Umar Shah, Goran Stojanovic, Sanja Kojic, Armin Mooranian & Hani Al-Salami. (2020) Alginate-based drug oral targeting using bio-micro/nano encapsulation technologies. Expert Opinion on Drug Delivery 17:10, pages 1361-1376.
Read now
Read now
Jeremiah D Momper & Sanjay K Nigam. (2018) Developmental regulation of kidney and liver solute carrier and ATP-binding cassette drug transporters and drug metabolizing enzymes: the role of remote organ communication. Expert Opinion on Drug Metabolism & Toxicology 14:6, pages 561-570.
Read now
Read now
Jost Klawitter, Björn Nashan & Uwe Christians. (2015) Everolimus and sirolimus in transplantation-related but different. Expert Opinion on Drug Safety 14:7, pages 1055-1070.
Read now
Read now
K.-M. Thai, N.-T. Huynh, T.-D. Ngo, T.-T. Mai, T.-H. Nguyen & T.-D. Tran. (2015) Three- and four-class classification models for P-glycoprotein inhibitors using counter-propagation neural networks. SAR and QSAR in Environmental Research 26:2, pages 139-163.
Read now
Read now
Saeed Alqahtani, Loqman A Mohamed & Amal Kaddoumi. (2013) Experimental models for predicting drug absorption and metabolism. Expert Opinion on Drug Metabolism & Toxicology 9:10, pages 1241-1254.
Read now
Read now
Shripad D. Chitnis, Ken Ogasawara, Björn Schniedewind, Reginald Y. Gohh, Uwe Christians & Fatemeh Akhlaghi. (2013) Concentration of tacrolimus and major metabolites in kidney transplant recipients as a function of diabetes mellitus and cytochrome P450 3A gene polymorphism. Xenobiotica 43:7, pages 641-649.
Read now
Read now
James E Cooper, Uwe Christians & Alexander C Wiseman. (2011) Everolimus in kidney transplantation. Transplant Research and Risk Management 3, pages 97-112.
Read now
Read now
Thierry Lavé, Kathryn Chapman, Paul Goldsmith & Malcolm Rowland. (2009) Human clearance prediction: shifting the paradigm. Expert Opinion on Drug Metabolism & Toxicology 5:9, pages 1039-1048.
Read now
Read now
Articles from other publishers (87)
Louise Wray, Joris Berwaerts, David Critchley, Kerry Hyland, Cuiping Chen, Ching Thai & Bola Tayo. (2023) Pharmacokinetic Drug‐Drug Interaction With Coadministration of Cannabidiol and Everolimus in a Phase 1 Healthy Volunteer Trial. Clinical Pharmacology in Drug Development 12:9, pages 911-919.
Crossref
Crossref
Lara Marques & Nuno Vale. (2023) Unraveling the Impact of Salbutamol Polytherapy: Clinically Relevant Drug Interactions. Future Pharmacology 3:1, pages 296-316.
Crossref
Crossref
Muktika Tekade, Prashant L. Pingale, Sakshi P. Wani, Kuldeep Rajpoot, Nagaraja Sreeharsha, Mrudul Deshpande, Rakesh Kumar Tekade & Mukesh C. Sharma. 2023. Essentials of Pharmatoxicology in Drug Research, Volume 1. Essentials of Pharmatoxicology in Drug Research, Volume 1
469
505
.
Liliana Czornyj, Jerónimo Auzmendi & Alberto Lazarowski. 2023. Pharmacoresistance in Epilepsy. Pharmacoresistance in Epilepsy
177
206
.
Youssef Libiad, Saber Boutayeb & Aicha Chaibi. (2022) Interactions médicamenteuses des inhibiteurs de tyrosine kinase dans le traitement du cancer bronchique non à petites cellules. Bulletin du Cancer 109:3, pages 358-381.
Crossref
Crossref
Sameer Urgaonkar, Kamil Nosol, Ahmed M. Said, Nader N. Nasief, Yahao Bu, Kaspar P. Locher, Johnson Y. N. Lau & Michael P. Smolinski. (2021) Discovery and Characterization of Potent Dual P-Glycoprotein and CYP3A4 Inhibitors: Design, Synthesis, Cryo-EM Analysis, and Biological Evaluations. Journal of Medicinal Chemistry 65:1, pages 191-216.
Crossref
Crossref
Sreemoyee Chatterjee, Shalini Jain, Ritu Jangid & Mukesh Kumar Sharma. 2022.
225
258
.
Alan Talevi & Carolina L. Bellera. 2022. The ADME Encyclopedia. The ADME Encyclopedia
185
189
.
Alan Talevi & Carolina L. Bellera. 2022. The ADME Encyclopedia. The ADME Encyclopedia
958
965
.
Xiaoyu Sun, Shunxiong Tang, Binbin Hou, Zhijun Duan, Zhen Liu, Yang Li, Shoucheng He, Qiuming Wang & Qingyong Chang. (2021) Overexpression of P-glycoprotein, MRP2, and CYP3A4 impairs intestinal absorption of octreotide in rats with portal hypertension. BMC Gastroenterology 21:1.
Crossref
Crossref
Sonia Saib & Xavier Delavenne. (2021) Inflammation Induces Changes in the Functional Expression of P-gp, BCRP, and MRP2: An Overview of Different Models and Consequences for Drug Disposition. Pharmaceutics 13:10, pages 1544.
Crossref
Crossref
Noor Safwah Damanhuri, Endang Kumolosasi, Marhanis Salihah Omar, Amirul Faiz Abd Razak & Ahmad Hasnan Mansor. (2021) The influence of P-glycoprotein expression in the standard treatment of Helicobacter pylori infection in Sprague Dawley rats. DARU Journal of Pharmaceutical Sciences 29:1, pages 13-22.
Crossref
Crossref
Muzaffar Iqbal. 2021. Bioactive Compounds in Nutraceutical and Functional Food for Good Human Health. Bioactive Compounds in Nutraceutical and Functional Food for Good Human Health.
Charles Awortwe, Henrike Bruckmueller, Meike Kaehler & Ingolf Cascorbi. (2021)
Interaction of Phytocompounds of
Echinacea purpurea
with ABCB1 and ABCG2 Efflux Transporters
. Molecular Pharmaceutics 18:4, pages 1622-1633.
Crossref
Crossref
Marie Shinohara, Hiroshi Arakawa, Yuuichi Oda, Nobuaki Shiraki, Shinji Sugiura, Takumi Nishiuchi, Taku Satoh, Keita Iino, Sylvia Leo, Yusuke Kato, Karin Araya, Takumi Kawanishi, Tomoki Nakatsuji, Manami Mitsuta, Kosuke Inamura, Tomomi Goto, Kenta Shinha, Wataru Nihei, Kikuo Komori, Masaki Nishikawa, Shoen Kume, Yukio Kato, Toshiyuki Kanamori, Yasuyuki Sakai & Hiroshi Kimura. (2021) Coculture with hiPS-derived intestinal cells enhanced human hepatocyte functions in a pneumatic-pressure-driven two-organ microphysiological system. Scientific Reports 11:1.
Crossref
Crossref
Alan Talevi & Carolina L. Bellera. 2021. The ADME Encyclopedia. The ADME Encyclopedia
1
8
.
Lydia R. Engwenyu & Allen S. Anderson. 2022. Pharmacology of Immunosuppression. Pharmacology of Immunosuppression
27
38
.
Herman Veenhof, Hugo M. Schouw, Martine T. P. Besouw, Daan J. Touw & Valentina Gracchi. (2020) Flucloxacillin decreases tacrolimus blood trough levels: a single-center retrospective cohort study. European Journal of Clinical Pharmacology 76:12, pages 1667-1673.
Crossref
Crossref
Sanjay K. Nigam, Kevin T. Bush, Vibha Bhatnagar, Samuel M. Poloyac & Jeremiah D. Momper. (2020) The Systems Biology of Drug Metabolizing Enzymes and Transporters: Relevance to Quantitative Systems Pharmacology. Clinical Pharmacology & Therapeutics 108:1, pages 40-53.
Crossref
Crossref
Guido FillerMara Medeiros & Maria E. Díaz-González de Ferris. (2020) Appreciating the Impact of Tacrolimus Sampling Time Deviations in Pediatric Patients With Nephrotic Syndrome. Therapeutic Drug Monitoring 42:3, pages 354-356.
Crossref
Crossref
Danyi Lu, Mengjing Zhao, Min Chen & Baojian Wu. (2020) Circadian Clock–Controlled Drug Metabolism: Implications for Chronotherapeutics. Drug Metabolism and Disposition 48:5, pages 395-406.
Crossref
Crossref
Aaftab S. Shaikh, Asha B. Thomas & Sohan S. Chitlange. (2020) Herb–drug interaction studies of herbs used in treatment of cardiovascular disorders—A narrative review of preclinical and clinical studies. Phytotherapy Research 34:5, pages 1008-1026.
Crossref
Crossref
Maaike A. Sikma, Claudine C. Hunault, Alwin D. R. Huitema, Dylan W. De Lange & Erik M. Van Maarseveen. (2019) Clinical Pharmacokinetics and Impact of Hematocrit on Monitoring and Dosing of Tacrolimus Early After Heart and Lung Transplantation. Clinical Pharmacokinetics 59:4, pages 403-408.
Crossref
Crossref
Harshad B. Patel, Urvesh D. Patel, Basavaraj S. Mathapati & Chirag M. Modi. (2019) Effect of piperine and quercetin alone or in combination with marbofloxacin on CYP3A37 and MDR1 mRNA expression levels in broiler chickens. Research in Veterinary Science 126, pages 178-183.
Crossref
Crossref
Drishti Rathod, Yige Fu & Ketan Patel. (2019) BRD4 PROTAC as a novel therapeutic approach for the treatment of vemurafenib resistant melanoma: Preformulation studies, formulation development and in vitro evaluation. European Journal of Pharmaceutical Sciences 138, pages 105039.
Crossref
Crossref
Shinji Yamazaki, Chester Costales, Sarah Lazzaro, Soraya Eatemadpour, Emi Kimoto & Manthena V. Varma. (2019) Physiologically‐Based Pharmacokinetic Modeling Approach to Predict Rifampin‐Mediated Intestinal P‐Glycoprotein Induction. CPT: Pharmacometrics & Systems Pharmacology 8:9, pages 634-642.
Crossref
Crossref
Paolo Gallo, Antonio De Vincentis, Claudio Pedone, Alessandro Nobili, Mauro Tettamanti, Umberto Vespasiani Gentilucci, Antonio Picardi, Pier Mannuccio Mannucci & Raffaele Antonelli Incalzi. (2019) Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients. European Journal of Internal Medicine 65, pages 51-57.
Crossref
Crossref
Renée Dagenais, Marianna Leung, Krishna Poinen & David Landsberg. (2018) Common Questions and Misconceptions in the Management of Renal Transplant Patients: A Guide for Health Care Providers in the Posttransplant Setting. Annals of Pharmacotherapy 53:4, pages 419-429.
Crossref
Crossref
Jingjing Yu, Ichiko D. Petrie, René H. Levy & Isabelle Ragueneau-Majlessi. (2019) Mechanisms and Clinical Significance of Pharmacokinetic-Based Drug-Drug Interactions with Drugs Approved by the U.S. Food and Drug Administration in 2017. Drug Metabolism and Disposition 47:2, pages 135-144.
Crossref
Crossref
Sigrun Chrubasik-Hausmann, Julia Vlachojannis & Andrew J McLachlan. (2019)
Understanding drug interactions with St John's wort (
Hypericum perforatum
L.): impact of hyperforin content
. Journal of Pharmacy and Pharmacology 71:1, pages 129-138.
Crossref
Crossref
Justin D. Lutz, Brian J. Kirby, Lu Wang, Qinghua Song, John Ling, Benedetta Massetto, Angela Worth, Brian P. Kearney & Anita Mathias. (2018) Cytochrome P450 3A Induction Predicts P‐glycoprotein Induction; Part 1: Establishing Induction Relationships Using Ascending Dose Rifampin. Clinical Pharmacology & Therapeutics 104:6, pages 1182-1190.
Crossref
Crossref
Justin D. Lutz, Brian J. Kirby, Lu Wang, Qinghua Song, John Ling, Benedetta Massetto, Angela Worth, Brian P. Kearney & Anita Mathias. (2018) Cytochrome P450 3A Induction Predicts P‐glycoprotein Induction; Part 2: Prediction of Decreased Substrate Exposure After Rifabutin or Carbamazepine. Clinical Pharmacology & Therapeutics 104:6, pages 1191-1198.
Crossref
Crossref
Jingjing Yu, Zhu Zhou, Jessica Tay-Sontheimer, René H. Levy & Isabelle Ragueneau-Majlessi. (2018) Risk of Clinically Relevant Pharmacokinetic-Based Drug-Drug Interactions with Drugs Approved by the U.S. Food and Drug Administration Between 2013 and 2016. Drug Metabolism and Disposition 46:6, pages 835-845.
Crossref
Crossref
Robert Hermann, Hartmut Derendorf, Oliver von Richter & Amin Rostami‐Hodjegan. (2018) Core Entrustable Professional Activities in Clinical Pharmacology: Pearls for Clinical Practice. The Journal of Clinical Pharmacology 58:6, pages 704-716.
Crossref
Crossref
Peter O. Oladimeji & Taosheng Chen. (2018) PXR: More Than Just a Master Xenobiotic Receptor. Molecular Pharmacology 93:2, pages 119-127.
Crossref
Crossref
Daisuke Satoh, Satoshi Abe, Kaoru Kobayashi, Yoshihiro Nakajima, Mitsuo Oshimura & Yasuhiro Kazuki. (2018) Human and mouse artificial chromosome technologies for studies of pharmacokinetics and toxicokinetics. Drug Metabolism and Pharmacokinetics 33:1, pages 17-30.
Crossref
Crossref
Peihe ZhengYinbin ChenYangyang FuHecheng WangJia WangSiwen ZhengShengyuan XiaoYingping Wang. (2017)
Influence of B-Complex Vitamins on the Pharmacokinetics of Ginsenosides Rg
1
, Rb
1
, and Ro After Oral Administration
. Journal of Medicinal Food 20:11, pages 1127-1132.
Crossref
Crossref
Ana C. Alvarez-Elías, Elisa C. Yoo, Ekaterina K. Todorova, Ram N. Singh & Guido Filler. (2017) A Retrospective Study on Mycophenolic Acid Drug Interactions: Effect of Prednisone, Sirolimus, and Tacrolimus With MPA. Therapeutic Drug Monitoring 39:3, pages 220-228.
Crossref
Crossref
Meng-Syuan Yang, Chung-Ping Yu, Ching-Ya Huang, Pei-Dawn Lee Chao, Shiuan-Pey Lin & Yu-Chi Hou. (2017) Aloe activated P-glycoprotein and CYP 3A: a study on the serum kinetics of aloe and its interaction with cyclosporine in rats. Food & Function 8:1, pages 315-322.
Crossref
Crossref
Enoche F. Oga, Shuichi Sekine, Yoshihisa Shitara & Toshiharu Horie. (2015) Pharmacokinetic Herb-Drug Interactions: Insight into Mechanisms and Consequences. European Journal of Drug Metabolism and Pharmacokinetics 41:2, pages 93-108.
Crossref
Crossref
Guido Filler & Lisa A. Robinson. (2015) Should we stop dosing steroids per body surface area for nephrotics?. Pediatric Nephrology 31:4, pages 519-522.
Crossref
Crossref
M. Sabet-Baktach, V. Schmitz & J. Pratschke. (2016) Trauma-Management beim organtransplantierten PatientenTrauma management of patients after organ transplantation. Notfall + Rettungsmedizin 19:2, pages 143-157.
Crossref
Crossref
Guido Filler, Amrit Kirpalani & Bradley L. Urquhart. 2016. Pediatric Nephrology. Pediatric Nephrology
2267
2293
.
Guido Filler, Amrit Kirpalani & Bradley L. Urquhart. 2014. Pediatric Nephrology. Pediatric Nephrology
1
28
.
Guido Filler & Norman Smith. (2014) The Need for Tacrolimus Assay Standardization. Therapeutic Drug Monitoring 36:6, pages 693-695.
Crossref
Crossref
Kevin Bax, Janice Tijssen, Michael J. Rieder & Guido Filler. (2014) Rapid Resolution of Tacrolimus Intoxication–Induced AKI With a Corticosteroid and Phenytoin. Annals of Pharmacotherapy 48:11, pages 1525-1528.
Crossref
Crossref
Michaela Böhmdorfer, Alexandra Maier-Salamon, Juliane Riha, Stefan Brenner, Martina Höferl & Walter Jäger. (2014) Interplay of drug metabolizing enzymes with cellular transportersZusammenspiel von arzneistoffmetabolisierenden Enzymen mit zellulären Transportern. Wiener Medizinische Wochenschrift 164:21-22, pages 461-471.
Crossref
Crossref
Yasuyuki Inoue, Tasuku Saito, Kohei Ogawa, Yuji Nishio, Shigeki Kosugi, Yoshinori Suzuki, Masayuki Kato, Hirotaka Sakai, Masatomo Takahashi & Ikuo Miura. (2014) Pharmacokinetics of Cyclosporine a Conversion From Twice-Daily Infusion to Oral Administration in Allogeneic Hematopoietic Stem Cell Transplantation. American Journal of Therapeutics 21:5, pages 377-384.
Crossref
Crossref
Lori A. Gardner, Jelena Klawitter, Mark A. Gregory, Vadym Zaberezhnyy, Dmitry Baturin, Daniel A. Pollyea, Naoko Takebe, Uwe Christians, Lia Gore, James DeGregori & Christopher C. Porter. (2014)
Inhibition of calcineurin combined with dasatinib has direct and indirect anti-leukemia effects against BCR-ABL1
+
leukemia
. American Journal of Hematology 89:9, pages 896-903.
Crossref
Crossref
Els Van Peer, Evy Verbueken, Moayad Saad, Christophe Casteleyn, Chris Van Ginneken & Steven Van Cruchten. (2014) Ontogeny of CYP3A and P-Glycoprotein in the Liver and the Small Intestine of the Göttingen Minipig: An Immunohistochemical Evaluation. Basic & Clinical Pharmacology & Toxicology 114:5, pages 387-394.
Crossref
Crossref
Thaddaus Hellwig & Michael Gulseth. (2013) Pharmacokinetic and Pharmacodynamic Drug Interactions With New Oral Anticoagulants. Annals of Pharmacotherapy 47:11, pages 1478-1487.
Crossref
Crossref
Tomoko Morisaki, Xiao-Long Hou, Kyoko Takahashi & Koichi Takahashi. (2013) Baicalin pharmacokinetic profile of absorption process using novel in-vitro model: cytochrome P450 3A4-induced Caco-2 cell monolayers combined with rat intestinal rinse fluids. Journal of Pharmacy and Pharmacology 65:10, pages 1526-1535.
Crossref
Crossref
Linda W. Moore. (2013) Food, Food Components, and Botanicals Affecting Drug Metabolism in Transplantation. Journal of Renal Nutrition 23:3, pages e71-e73.
Crossref
Crossref
Karl Henrik Johannes Ehinger, Magnus Joakim Hansson, Fredrik Sjövall & Eskil Elmér. (2012) Bioequivalence and Tolerability Assessment of a Novel Intravenous Ciclosporin Lipid Emulsion Compared to Branded Ciclosporin in Cremophor® EL. Clinical Drug Investigation 33:1, pages 25-34.
Crossref
Crossref
Jaime A. Yáñez, Nagendra V. Chemuturi, Scott W. Womble, Casey L. Sayre & Neal M. Davies. 2012. FLAVONOID PHARMACOKINETICS. FLAVONOID PHARMACOKINETICS
281
319
.
Rahul Vats, Kanthikiran V. S. Varanasi, Rambabu Arla, Sridhar Veeraraghvan & Shraddha Rajak. (2012) Drug–drug interaction study to assess the effects of atorvastatin co‐administration on pharmacokinetics and anti‐thrombotic properties of cilostazol in male Wistar rats. Biopharmaceutics & Drug Disposition 33:8, pages 455-465.
Crossref
Crossref
Rahul Bohra, Wenzel Schöning, Jelena Klawitter, Nina Brunner, Volker Schmitz, Touraj Shokati, Ryan Lawrence, Maria Fernanda Arbelaez, Björn Schniedewind, Uwe Christians & Jost Klawitter. (2012) Everolimus and Sirolimus in Combination with Cyclosporine Have Different Effects on Renal Metabolism in the Rat. PLoS ONE 7:10, pages e48063.
Crossref
Crossref
Rahul Vats, Kanthikiran V S Varanasi, Rambabu Arla, Sridhar Veeraraghavan, Shraddha Rajak & Aditya Narasimha Murthy. (2012) Effect of multidose cilostazol on pharmacokinetic and lipid profile of atorvastatin in male Wistar rats. Journal of Pharmacy and Pharmacology 64:11, pages 1638-1645.
Crossref
Crossref
Heidrun Potschka. (2012) Role of CNS efflux drug transporters in antiepileptic drug delivery: Overcoming CNS efflux drug transport. Advanced Drug Delivery Reviews 64:10, pages 943-952.
Crossref
Crossref
E. S. EL Desoky, S. N. Sabarinath, M. M. Hamdi, M. Bewernitz & H. Derendorf. (2012) Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients. Journal of Clinical Pharmacy and Therapeutics 37:3, pages 352-355.
Crossref
Crossref
Jorge Sepulveda. 2012. Pharmacogenomics of Alcohol and Drugs of Abuse. Pharmacogenomics of Alcohol and Drugs of Abuse
165
194
.
Oihane Diaz de Cerio, Eider Bilbao, Miren P. Cajaraville & Ibon Cancio. (2012) Regulation of xenobiotic transporter genes in liver and brain of juvenile thicklip grey mullets (Chelon labrosus) after exposure to Prestige-like fuel oil and to perfluorooctane sulfonate. Gene 498:1, pages 50-58.
Crossref
Crossref
Y. Inoue, T. Saito, K. Ogawa, Y. Nishio, S. Kosugi, Y. Suzuki, Y. Shibuya, M. Kato, M. Takahashi & I. Miura. (2011) Pharmacokinetics of cyclosporine A at a high-peak concentration of twice-daily infusion and oral administration in allogeneic haematopoietic stem cell transplantation. Journal of Clinical Pharmacy and Therapeutics 36:4, pages 518-524.
Crossref
Crossref
Robert A. B. van Waterschoot & Alfred H. Schinkel. (2011) A Critical Analysis of the Interplay between Cytochrome P450 3A and P-Glycoprotein: Recent Insights from Knockout and Transgenic Mice. Pharmacological Reviews 63:2, pages 390-410.
Crossref
Crossref
S. MODRIC & M. MARTINEZ. (2011) Patient variation in veterinary medicine - Part II - Influence of physiological variables. Journal of Veterinary Pharmacology and Therapeutics 34:3, pages 209-223.
Crossref
Crossref
Claudia Suenderhauf, Felix Hammann, Andreas Maunz, Christoph Helma & Jörg Huwyler. (2010) Combinatorial QSAR Modeling of Human Intestinal Absorption. Molecular Pharmaceutics 8:1, pages 213-224.
Crossref
Crossref
Kyoung-Ah Kim & Ji-Young Park. (2010) Effect of metronidazole on the pharmacokinetics of fexofenadine, a P-glycoprotein substrate, in healthy male volunteers. European Journal of Clinical Pharmacology 66:7, pages 721-725.
Crossref
Crossref
Jianghong Fan, Han‐Joo Maeng & K. Sandy Pang. (2010) Interplay of transporters and enzymes in the Caco‐2 cell monolayer: I. effect of altered apical secretion. Biopharmaceutics & Drug Disposition 31:4, pages 215-227.
Crossref
Crossref
Ruiwen Zhang & Elizabeth R. Rayburn. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
34
.
Yan Zhang & Donald W. Miller. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
22
.
Nicola Antonio Colabufo, Francesco Berardi, Mariangela Cantore, Marialessandra Contino, Carmela Inglese, Mauro Niso & Roberto Perrone. (2009) Perspectives of P-Glycoprotein Modulating Agents in Oncology and Neurodegenerative Diseases: Pharmaceutical, Biological, and Diagnostic Potentials. Journal of Medicinal Chemistry 53:5, pages 1883-1897.
Crossref
Crossref
Uwe Christians, Jelena Klawitter & Claudia F. Clavijo. (2010) Bioequivalence testing of immunosuppressants: concepts and misconceptions. Kidney International 77, pages S1-S7.
Crossref
Crossref
Xiang-Rui Wang, Zeng-Qiang Qu, Xiao-Dong Li, Hai-Lin Liu, Ping He, Bei-Xiong Fang, Jie Xiao, Wei Huang & Meng-Chao Wu. (2010) Activity of sulfotransferase 1A1 is dramatically upregulated in patients with hepatocellular carcinoma secondary to chronic hepatitis B virus infection. Cancer Science 101:2, pages 412-415.
Crossref
Crossref
K. Sandy Pang, Han-Joo Maeng & Jianghong Fan. (2009) Interplay of Transporters and Enzymes in Drug and Metabolite Processing. Molecular Pharmaceutics 6:6, pages 1734-1755.
Crossref
Crossref
Walter Jäger. 2009. Transporters as Drug Carriers. Transporters as Drug Carriers
325
347
.
Claudia R. Felipe, Sung-In Park, Paula G. Pinheiro-Machado, Riberto Garcia, Dulce E. Casarini, Silvia Moreira, Helio Tedesco-Silva Jr & Jose O. Medina-Pestana. (2009) Cyclosporine and sirolimus pharmacokinetics and drug-to-drug interactions in kidney transplant recipients. Fundamental & Clinical Pharmacology 23:5, pages 625-631.
Crossref
Crossref
Douglas M. Ruderfer, David C. Roberts, Stuart L. Schreiber, Ethan O. Perlstein & Leonid Kruglyak. (2009) Using Expression and Genotype to Predict Drug Response in Yeast. PLoS ONE 4:9, pages e6907.
Crossref
Crossref
Angela Storka & Johannes Pleiner. (2009) Medikamenteninteraktionen in der GeriatrieDrug interactions in geriatric medicine. Wiener Medizinische Wochenschrift 159:17-18, pages 462-469.
Crossref
Crossref
Sukhwinder S Lakhman, Qing MaGene D Morse. (2009)
Pharmacogenomics of
CYP3A
: considerations for HIV treatment
. Pharmacogenomics 10:8, pages 1323-1339.
Crossref
Crossref
Maria Alice Vieira WillrichMario Hiroyuki HirataRosario Dominguez Crespo Hirata. (2009) Statin regulation of CYP3A4 and CYP3A5 expression. Pharmacogenomics 10:6, pages 1017-1024.
Crossref
Crossref
Wolfgang Löscher, Ulrich Klotz, Fritz Zimprich & Dieter Schmidt. (2009) The clinical impact of pharmacogenetics on the treatment of epilepsy. Epilepsia 50:1, pages 1-23.
Crossref
Crossref
Shaojun Shi, Klaus Mörike & Ulrich Klotz. (2008) The clinical implications of ageing for rational drug therapy. European Journal of Clinical Pharmacology 64:2, pages 183-199.
Crossref
Crossref
Sheila Annie Peters. (2008) Identification of Intestinal Loss of a Drug through Physiologically Based Pharmacokinetic??Simulation of Plasma??Concentration-Time Profiles. Clinical Pharmacokinetics 47:4, pages 245-259.
Crossref
Crossref
Tobin Strom, Manuel Haschke, Yan Ling Zhang, Jamie Bendrick-Peart, Jared Boyd, Mark Roberts, Lili Arabshahi, Peter Marbach & Uwe Christians. (2007) Identification of Everolimus Metabolite Patterns in Trough Blood Samples of Kidney Transplant Patients. Therapeutic Drug Monitoring 29:5, pages 592-599.
Crossref
Crossref
Charles U. Nnadi & Anil K. Malhotra. (2007) Individualizing antipsychotic drug therapy in schizophrenia: The promise of pharmacogenetics. Current Psychiatry Reports 9:4, pages 313-318.
Crossref
Crossref
Louise Mallet, Anne Spinewine & Allen Huang. (2007) The challenge of managing drug interactions in elderly people. The Lancet 370:9582, pages 185-191.
Crossref
Crossref
Carol W. Holtzman, Barbara S. Wiggins & Sarah A. Spinler. (2012) Role of P‐glycoprotein in Statin Drug Interactions. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 26:11, pages 1601-1607.
Crossref
Crossref